194 related articles for article (PubMed ID: 21316805)
1. Imipenem and ciprofloxacin consumption as factors associated with high incidence rates of resistant Pseudomonas aeruginosa in hospitals in northern France.
Miliani K; L'Hériteau F; Lacavé L; Carbonne A; Astagneau P;
J Hosp Infect; 2011 Apr; 77(4):343-7. PubMed ID: 21316805
[TBL] [Abstract][Full Text] [Related]
2. Clinical, microbiologic, and epidemiologic characteristics of Pseudomonas aeruginosa infections in a University Hospital, Malatya, Turkey.
Yetkin G; Otlu B; Cicek A; Kuzucu C; Durmaz R
Am J Infect Control; 2006 May; 34(4):188-92. PubMed ID: 16679175
[TBL] [Abstract][Full Text] [Related]
3. [Evolution of antimicrobial resistance against Pseudomonas aeruginosa in a French university hospital between 2002 and 2006].
Minchella A; Molinari L; Alonso S; Bouziges N; Sotto A; Lavigne JP
Pathol Biol (Paris); 2010 Feb; 58(1):1-6. PubMed ID: 19875241
[TBL] [Abstract][Full Text] [Related]
4. Fluoroquinolone resistance of Pseudomonas aeruginosa isolates causing nosocomial infection is correlated with levofloxacin but not ciprofloxacin use.
Lee YJ; Liu HY; Lin YC; Sun KL; Chun CL; Hsueh PR
Int J Antimicrob Agents; 2010 Mar; 35(3):261-4. PubMed ID: 20045290
[TBL] [Abstract][Full Text] [Related]
5. Previous ciprofloxacin exposure is associated with resistance to beta-lactam antibiotics in subsequent Pseudomonas aeruginosa bacteremic isolates.
López-Dupla M; Martínez JA; Vidal F; Almela M; Soriano A; Marco F; López J; Olona M; Mensa J
Am J Infect Control; 2009 Nov; 37(9):753-8. PubMed ID: 19487049
[TBL] [Abstract][Full Text] [Related]
6. Hospital-level rates of fluoroquinolone use and the risk of hospital-acquired infection with ciprofloxacin-nonsusceptible Pseudomonas aeruginosa.
Ray GT; Baxter R; DeLorenze GN
Clin Infect Dis; 2005 Aug; 41(4):441-9. PubMed ID: 16028150
[TBL] [Abstract][Full Text] [Related]
7. Relationship between rates of antimicrobial consumption and the incidence of antimicrobial resistance in Staphylococcus aureus and Pseudomonas aeruginosa isolates from 47 French hospitals.
Rogues AM; Dumartin C; Amadéo B; Venier AG; Marty N; Parneix P; Gachie JP
Infect Control Hosp Epidemiol; 2007 Dec; 28(12):1389-95. PubMed ID: 17994520
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial usage and resistance trend relationships from the MYSTIC Programme in North America (1999-2001).
Mutnick AH; Rhomberg PR; Sader HS; Jones RN
J Antimicrob Chemother; 2004 Feb; 53(2):290-6. PubMed ID: 14711839
[TBL] [Abstract][Full Text] [Related]
9. Analysis of resistance, cross-resistance and antimicrobial combinations for Pseudomonas aeruginosa isolates from 1997 to 2009.
Master RN; Clark RB; Karlowsky JA; Ramirez J; Bordon JM
Int J Antimicrob Agents; 2011 Oct; 38(4):291-5. PubMed ID: 21737249
[TBL] [Abstract][Full Text] [Related]
10. Effect of a program to reduce hospital ciprofloxacin use on nosocomial Pseudomonas aeruginosa susceptibility to quinolones and other antimicrobial agents.
Cook PP; Das TD; Gooch M; Catrou PG
Infect Control Hosp Epidemiol; 2008 Aug; 29(8):716-22. PubMed ID: 18590455
[TBL] [Abstract][Full Text] [Related]
11. Clinical surveillance of surgical imipenem-resistant Pseudomonas aeruginosa infection in a Japanese hospital.
Sasaki M; Hiyama E; Takesue Y; Kodaira M; Sueda T; Yokoyama T
J Hosp Infect; 2004 Feb; 56(2):111-8. PubMed ID: 15019222
[TBL] [Abstract][Full Text] [Related]
12. Clinical impact of imipenem-resistant Pseudomonas aeruginosa bloodstream infections.
Suárez C; Peña C; Tubau F; Gavaldà L; Manzur A; Dominguez MA; Pujol M; Gudiol F; Ariza J
J Infect; 2009 Apr; 58(4):285-90. PubMed ID: 19297028
[TBL] [Abstract][Full Text] [Related]
13. Dissemination of Pseudomonas aeruginosa producing SPM-1-like and IMP-1-like metallo-beta-lactamases in hospitals from southern Brazil.
Martins AF; Zavascki AP; Gaspareto PB; Barth AL
Infection; 2007 Dec; 35(6):457-60. PubMed ID: 18034208
[TBL] [Abstract][Full Text] [Related]
14. Correlation between fluoroquinolone consumption in hospitals and ciprofloxacin resistance amongst Pseudomonas aeruginosa isolates causing healthcare-associated infections, Taiwan, 2000-2009.
Weng TC; Chen YH; Lee CC; Wang CY; Lai CC; Tang HJ; Ko WC; Hsueh PR
Int J Antimicrob Agents; 2011 Jun; 37(6):581-4. PubMed ID: 21489757
[No Abstract] [Full Text] [Related]
15. Investigation of a nosocomial outbreak by alginate-producing pan-antibiotic-resistant Pseudomonas aeruginosa.
Yakupogullari Y; Otlu B; Dogukan M; Gursoy C; Korkmaz E; Kizirgil A; Ozden M; Durmaz R
Am J Infect Control; 2008 Dec; 36(10):e13-8. PubMed ID: 19084158
[TBL] [Abstract][Full Text] [Related]
16. Surveillance of multi-drug resistant Pseudomonas aeruginosa in an urban tertiary-care teaching hospital.
Jung R; Fish DN; Obritsch MD; MacLaren R
J Hosp Infect; 2004 Jun; 57(2):105-11. PubMed ID: 15183239
[TBL] [Abstract][Full Text] [Related]
17. Distributed lags time series analysis versus linear correlation analysis (Pearson's r) in identifying the relationship between antipseudomonal antibiotic consumption and the susceptibility of Pseudomonas aeruginosa isolates in a single Intensive Care Unit of a tertiary hospital.
Erdeljić V; Francetić I; Bošnjak Z; Budimir A; Kalenić S; Bielen L; Makar-Aušperger K; Likić R
Int J Antimicrob Agents; 2011 May; 37(5):467-71. PubMed ID: 21277747
[TBL] [Abstract][Full Text] [Related]
18. [Four years of monitoring of antibiotic sensitivity rates of Pseudomonas aeruginosa and Acinetobacter baumannii strains isolated from patients in intensive care unit and inpatient clinics].
Alişkan H; Colakoğlu S; Turunç T; Demiroğlu YZ; Erdoğan F; Akin S; Arslan H
Mikrobiyol Bul; 2008 Apr; 42(2):321-9. PubMed ID: 18697430
[TBL] [Abstract][Full Text] [Related]
19. The impact of fluoroquinolones use on antibiotic resistance in an intensive care burn department.
Thabet L; Memmi M; Turki A; Messadi AA
Tunis Med; 2010 May; 88(5):297-300. PubMed ID: 20517823
[TBL] [Abstract][Full Text] [Related]
20. An outbreak of imipenem-resistant Pseudomonas aeruginosa in an intensive care unit.
Majumdar S; Kirby A; Berry N; Williams C; Hassan I; Eddleston J; Burnie JP
J Hosp Infect; 2004 Oct; 58(2):160-1. PubMed ID: 15474190
[No Abstract] [Full Text] [Related]
[Next] [New Search]
